BD Micro-Fine Ultra™ 4mm

0,23mm (32g) Pen Needle

Pentapoint Technology

Clinically demonstrated to reduce the pain of injection1

Improved insulin absorption

Simple injection technique, without lifted skin fold in most patients4.

Reduces Risk of Hyperglycemia

Contributes to reducing the risks of injecting into the muscle and therefore may help to reduce the risk of hypoglycaemia2.

Related Products


Please note, not all products, services or features of products and services may be available in your local area. Please check with your local BD representative.

References
  1. Hirsch L, et al. The impact of a modified needle tip geometry on penetration force as well as acceptability, preference and perceived pain in subjects with diabetes. J Diab Sci Tech 2012.
  2. Frid Anders, Ostman Jan & Linde Brigitta. Hypoglycaemia Risk During Exercise After Intramuscular Injection of Insulin in Thigh in IDDM. Diabetes Care, Vol. 13, No. 5, May 1990, 473-477.
  3. Gibney MA, Arce CH, Byron KJ, Hirsch LJ. Skin and subcutaneous adipose layer thickness in adults with diabetes at sites used for insulin injections: implications for needle length recommendations. Curr Med Res Opin 2010;26:1519-30.
  4. Frid A.et al, New Injection Recommendations for Patients with Diabetes, Diabetes & Metabolism, September 2010, Vol.36, Special issue 2.